The American Society of Clinical Oncology (ASCO) is collaborating with SAP on an big data initiative to use EHRs in order to examine early identification on potential cancer patients.
SAP’s software includes predictive text analytics, spatial processing and data virtualization. The collaboration with ASCO is one of several health-related efforts for SAP, having previously applied its software with the National Center for Tumor Diseases in Germany, to assist cancer research and improve clinical trial matching. In Japan, SAP has teamed with Mitsui Knowledge Industry to reduce patient-specific genomic analysis for cancer diagnosis from 30 days to 20 minutes. It also partnered with Stanford University on a genomic data effort.
Officials said seven more large cancer centers will soon join this effort, meaning approximately 500,000 patients will be represented in the first version of CancerLinQ. The eight that have already signed on are:
CancerLinQ’s vanguard practices include:
— Inova Comprehensive Cancer & Research Institute
— South Coast Centers for Cancer Care
— New England Cancer Specialists
— Medical Oncology Hematology Consultants, PA
— Cancer Treatment Centers of America
— Marin Cancer Care
— Space Coast Cancer Center
— Michiana Hematology-Oncology, P.C.
The ASCO will maintain control over the data, services, and products that stem from the platform, including clinical decision support tools and analyses.
